A.I

Artificial Intelligence Conferences | Oncodesign
A.I
28/04/2022

Places to meet and engage conversation with our experts in AI and Drug Discovery

Come back regularly to check if there is a meeting nearby your place to meet one of our experts in both AI & Drug Discovery.

A.I
06/01/2022

OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients

Early/ late resistance marker; Immunological profile; NGS; Non small-cell lung cancer; Pancreatic ductal adenocarcinoma; Triple negative breast or Luminal Breast Cancer.

EHDEN - The European Health Data & Evidence Network - Oncodesign
Corporate
A.I
28/10/2021

Oncodesign: EHDEN Certified SME

EHDEN network will enable transparent & fully reproducible research by standardizing both the health data & the analytical pipeline.

A.I
Financial
18/05/2021

InterSystems & Oncodesign partner for the optimization of data use to enhance and accelerate Drug Discovery processes in oncology

Read PRess Release to have an insight on how to organize & leverage healthcare data to accelerate the search for new treatments in oncology using AI.

Corporate
A.I
18/09/2018

Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED

Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.